Close
CDMO Safety Testing 2026
Novotech

News

The Parenteral Drug Administration โ€“ An Evolving Spectrum

Parenteral drug administration has gone on to witness quite a significant set of advancements as well as transformations in recent years. This very crucial method when it comes to drug delivery happens to be playing a very pivotal role when...

Respiratory Syncytial Virus Jab From Moderna Gets FDA Nod

Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine, which is for adults aged 60 years and older. It is well to be noted that...

Meaningful Investment To Enable Tirzepatide API Production

It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Companyโ€™s manufacturing site based in Lebanon, Indiana, US has gone on to raise the organizationโ€™s total investment in the country from...

Germany – Taking Right Steps Towards Pharma Drugs Reshoring

As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper in December 2023, which identified three major areas that need to be strengthened. The objectives include...

CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation

CordenPharma, a global CDMO leader in the manufacture of Drug Substances (APIs) for complex modalities (such as peptides, GalNAc, lipids, etc.), Lipid NanoParticles (LNPs) containing xRNA / xDNA,ย and injectable Drug Products, and Certest, a Spanish company focused on the...

How Dentists Can Make Patients Feel More Comfortable

Visiting the dentistย can be a source of anxiety and discomfort for many patients, regardless of their age or the procedure they require. However, creating a welcoming and comfortable environment is crucial for ensuring a positive patient experience and encouraging...

Green Chemistry Innovations Key To Pharma Solvent Sector

The pharmaceutical solvents sector has gone on to secure a valuation worth $3.9 billion in 2023 and is all set to scale the $6 billion mark by 2033 with a CAGR of 4.6% throughout the forecast period. Let us have...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป